Clinical Staging Tools for the Impacts of Obesity on Individuals

Morbid Obesity Clinical Trial

— COST  

Official title:

Assessing Clinical Staging Tools for Tracking the Impacts of Obesity on Individuals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01112228
• Other study ID #: Clinical Obesity Staging Tools
• Status: Completed
• Start date: October 2009
• Est. completion date: August 2011

Study information

• Verified date: October 2020
• Source: Imperial College London
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment.

Description:

This study will assess various published staging tools to assess the health impacts of obesity on individuals. The aim is to identify benefits and drawbacks, and thus help Obesity Centres and GPs better assess obese individuals as well as better identify who benefits most from having weight loss treatment

Recruitment information / eligibility

• Status: Completed
• Enrollment: 600
• Est. completion date: August 2011
• Est. primary completion date: August 2011
• Accepts healthy volunteers: No
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Morbid obesity
• At least 1 year follow-up after bariatric surgery

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Morbid Obesity
• Obesity
• Obesity, Morbid

Intervention

Procedure:
• Bariatric surgery
Bariatric surgery: Gastric bypass, Sleeve gastrectomy, or Gastric banding

Locations

Country	Name	City	State
United Kingdom	Imperial Weight Centre, Imperial College London	London

Sponsors (1)

Lead Sponsor	Collaborator
Imperial College London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in Obesity Scores After Weight Loss Treatment	Changes were measured in the following clinical domains; -Airway, Body Mass Index, Cardiovascular risk, Diabetes, Economic, Functional. Gonadal, Body Image.; An improvement was considered when any 1 of these domains changes for the positive. Thus, if a patient had an improvement in cardiovascular risk the intervention was considered beneficial even if no other domains changed.; Out measure is calculated as the count of participants achieving at least 1 improvement (Count)	Minimum of 1 year follow-up
Secondary	Changes in Obesity Scores in Various Subgroups	Changes in obesity scores in patients with carious co-morbid conditions (eg, type 2 diabetes, sleep apnoea) before bariatric surgery	Minimum of 1 year follow-up